Pharmaceutical price controls will choke off tens of billions of dollars of capital, curtailing research and preventing scores of new drugs from coming to market, writes Doug Badger in an op-ed.
Pharmaceutical price controls will choke off tens of billions of dollars of capital, curtailing research and preventing scores of new drugs from coming to market, writes Doug Badger in an op-ed.